The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation

Medicine & Life Sciences

• A549 Cells 9%
• Aerosols 13%
• Body Weight 5%
• Cell Cycle 3%
• Cisplatin 52%
• Drug Carriers 4%
• Epidermal Growth Factor 56%
• Gelatin 62%
• Growth 2%
• In Vitro Techniques 3%
• Inhalation 53%
• Inhibitory Concentration 50 3%
• Injections 2%
• Ligands 2%
• Lung 30%
• Lung Neoplasms 6%
• Nanoparticles 51%
• Neoplasms 2%
• Pharmaceutical Preparations 1%
• Poisons 3%
• Polymers 3%
• Population 1%
• SCID Mice 4%
• Staining and Labeling 2%
• Therapeutic Uses 3%
• Therapeutics 2%
• Weight Loss 6%

Engineering & Materials Science

• Aerosols 14%
• Cell growth 5%
• Cells 4%
• Epidermal Growth Factor 100%
• Ligands 5%
• Nanoparticles 56%
• Polymers 3%
• Tumors 8%

Chemical Compounds

• Aerosol 12%
• Cisplatin 62%
• Dose 3%
• Drug 2%
• Drug Carrier 4%
• Gelatin 58%
• Ligand 1%
• Modification 2%
• Nanoparticle 28%
• Toxic 3%
• Weight 4%